FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt. The invention also refers to pharmaceutical compositions containing the above citrate, and methods for using citrate in treating several conditions.
EFFECT: what is prepared is the new 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene salt and the pharmaceutical compositions on the basis thereof which can find application in medicine for treating a proliferative disorder.
17 cl, 30 dwg, 5 tbl, 6 ex
| Title |
Year |
Author |
Number |
| 9E-15-(2-PYRROLIDIN-1-YL-ETHOXY)-7,12,25-TRIOXA-19,21,24-TRIAZATETRACYCLO[18.3.1.1(2,5). 1(14,18)]HEXACOSA-1(24),2,4,9,14,16,18(26),20,22-NONAENE CITRATE SALT |
2010 |
- Dajmok Brajan
- Li Chehn' Khsija Andzhelin
- Vil'Jam Ehntoni Deodonija
|
RU2543721C2 |
| CRYSTALLINE FORMS OF 3-(2,6-DICHLORO-3,5-DIMETHOXYPHENYL)-1-{ 6-[4-(4-ETHYLPIPERAZIN-1-YL)-PHENYLAMINO]-PYRIMIDIN-4-YL} -1-METHYLUREA AND ITS FRACTIONS |
2010 |
- Jerg Bergkhauzen
- Prasad Kotesvara Kapa
- Dzhozef Makkenna
- Dzhoehl Slejd
- Rejann Vu
- Chzhehnmin Du
- Frank Shtovasser
|
RU2572848C2 |
| NONHYGROSCOPIC CRYSTALLINE 5-[(Z)-(5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[(2S)-2-HYDROXY-3-MORPHOLIN-4-YLPROPYL]-2,4-DIMETHYL-1H-PYRROL-3-CARBOXAMIDE MALEATE SALT, PHARMACEUTICAL COMPOSITION AND METHOD FOR CANCER TREATMENT |
2004 |
- Blasko Andrej
- Tszin' Tsinvu
- Lu Tsjun'
- Morejdzhis Majkl Ehntoni
- Song Dong
- Vondervell Brenda S'Ju
|
RU2319702C2 |
| (1S,2S,4R)-4-{4-[(1S)-2,3-DIHYDRO-1H-INDEN-1-YLAMINO]-7H-PYRROLO[2,3-d]PYRIMIDIN-7-YL}-2-HYDROXYCYCLOPENTYL)METHYL SULPHAMATE HYDROCHLORIDE |
2010 |
- Armitehjdzh Ian G.
- Chopra Reenu
- Kuper Martin Ian
- Lehngston Mehriann
- Lehngston Stefen P
- Viskochil Stepan
|
RU2562245C2 |
| POLYMORPHIC AND PSEUDOPOLYMORPHIC FORMS OF PHARMACEUTICAL COMPOUND |
2010 |
- Bhattachrya Sisir
- Bonnet Alain
- Dedhiya Mahendra G.
- Ducandas Veronigue
- Giuliani Alexandre
- Priour Alain
- Ravaux Valerie
- Spargo Peter
|
RU2575173C2 |
| POLYMORPHOUS AND PSEUDOPOLYMORPHOUS FORMS OF THE PHARMACEUTICAL COMPOUND |
2010 |
- Bhattacharya Sisir
- Bonnet Alain
- Dedhiya Mahendra G.
- Ducandas Veronique
- Giuliani Alexandre
- Priour Alain
- Ravaux Valerie
- Spargo Peter
|
RU2727509C2 |
| POLYMORPHS OF 4-[2-DIMETHYLAMINO-1-(1-HYDROXYCYCLOHEXYL)ETHYL]PHENYL 4-METHYLBENZOATE HYDROCHLORIDE, METHODS FOR OBTAINING THEREOF AND APPLICATION |
2011 |
- Li Youxin
- Liu Wanhui
- Lv Yang
- Du Guanhua
- Meng Qingguo
- Yang Mina
- Zhou Fengmei
- Li Ju
- Zhang Xuemei
|
RU2576665C2 |
| 4-[2-[[5-METHYL-1-(2-NAPHTHALINYL)-1H-PYRAZOL-3-YL]OXY]ETHYL]MORPHOLINE HYDROCHLORIDE POLYMORPH AND SOLVATES |
2011 |
- Berenger Majmo Ramon
- Medrano Ruperes Khorkhe
- Benet Bukhkhol'Ts Khordi
- Puig Fernandes Laura
- Pellekha Pukseu Laja
|
RU2560150C2 |
| CRYSTALLINE FORMS OF 1-(3-TRET-BUTYL-1-P-TOLYL-1H-PYRAZOL-5-YL)-3-(5-FLUORO-2-(1-(2-HYDROXYETIL)-1H-INDASOL-5-YLOXY)BENZYL) HYDROCHLORIDE UREA |
2013 |
- Errigo Alisha B.
- Korson Donald T.
- Mannila Korali G.
|
RU2627702C2 |
| (1R*,2R*,4R*)-2-(2-{[3(4,7-DIMETHOXY-1H-BENZOIMIDAZOL-2-YL)PROPYL]METHYLAMINO}ETHYL)-5-PHENYLBICYCLO[2,2,2]OCT-5-EN-2-YL ISOBUTYRIC ACID SALTS |
2009 |
- Shtefan Abele
- Stefani Kombe
- Zhak-Aleksis Fjunel'
- Kurt Khil'Pert
- Fransis Juble
- Katarina Rajkhenbehkher
- Dorte Renneberg
- Markus Fon Raumer
|
RU2516247C2 |
